Vimta Labs Limited
NSE: VIMTALABS BSE: VIMTALABS
Prev Close
432.8
Open Price
438.9
Volume
150,646
Today Low / High
435.5 / 447.6
52 WK Low / High
400.3 / 902.65
Range
423 - 468
Prev Close
433.9
Open Price
438
Volume
5,169
Today Low / High
435.4 / 447.45
52 WK Low / High
372.5 / 902.85
Range
423 - 467
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 445.7 (target range: 423 - 468), reflecting a change of 12.9 (2.98059%). On the BSE, it is listed at 444.95 (target range: 423 - 467), showing a change of 11.05 (2.54667%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Vimta Labs Limited Graph
Vimta Labs Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Vimta Labs Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 445.70, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 444.95 | 449.40 | 404.46 - 494.34 |
| 453.85 | 363.08 - 544.62 | ||
| 458.30 | 320.81 - 595.79 | ||
| Bearish Scenario | 444.95 | 440.50 | 396.45 - 484.55 |
| 436.05 | 348.84 - 523.26 | ||
| 431.60 | 302.12 - 561.08 |
Overview of Vimta Labs Limited
ISIN
INE579C01029
Industry
Medical - Diagnostics & Research
Vol.Avg
220,972
Market Cap
19,614,933,806
Last Dividend
1
Official Website
IPO Date
2005-12-15
DCF Diff
-868.78
DCF
1,359
Financial Ratios Every Investor Needs
Stock Dividend of VIMTALABS
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-05-30 | May 30, 25 | 1 | 1 | 2025-05-30 | 2025-06-16 | |
| 2024-07-11 | July 11, 24 | 2 | 2 | 2024-07-11 | 2024-07-25 | |
| 2023-06-21 | June 21, 23 | 2 | 2 | 2023-06-21 | 2023-07-07 | |
| 2022-06-16 | June 16, 22 | 2 | 2 | 2022-06-18 | 2022-06-30 | |
| 2021-06-25 | June 25, 21 | 2 | 2 | 2021-06-28 | 2021-07-12 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 343.98 Cr | 211.38 Cr | 132.60 Cr | 0.3855 | 0.00 Cr | 100.59 Cr | 87.82 Cr | 67.34 Cr | 15.14 | 126.19 Cr | 0.1958 |
| 2024-03-31 | 318.26 Cr | 76.29 Cr | 241.98 Cr | 0.7603 | 0.00 Cr | 10.28 Cr | 61.90 Cr | 41.01 Cr | 9.26 | 90.20 Cr | 0.1289 |
| 2023-03-31 | 315.06 Cr | 73.85 Cr | 241.21 Cr | 0.7656 | 0.00 Cr | 10.93 Cr | 69.68 Cr | 48.17 Cr | 10.89 | 96.64 Cr | 0.1529 |
| 2022-03-31 | 275.94 Cr | 184.53 Cr | 91.41 Cr | 0.3313 | 0.00 Cr | 8.60 Cr | 55.33 Cr | 41.33 Cr | 9.35 | 80.27 Cr | 0.1498 |
| 2021-03-31 | 208.57 Cr | 61.11 Cr | 147.45 Cr | 0.7070 | 1.12 Cr | 66.33 Cr | 36.08 Cr | 21.41 Cr | 4.84 | 53.35 Cr | 0.1026 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 15.84 Cr | 466.53 Cr | 87.68 Cr | 378.8480 Cr | 8.52 Cr | -7.32 Cr | 25.06 Cr | 261.67 Cr | 0.00 Cr | 8.22 Cr | 0.00 Cr | 64.3670 Cr |
| 2024-03-31 | 13.44 Cr | 400.05 Cr | 80.35 Cr | 319.6960 Cr | 19.19 Cr | 5.75 Cr | 24.69 Cr | 216.75 Cr | 0.00 Cr | 5.33 Cr | -9.36 Cr | 54.0700 Cr |
| 2023-03-31 | 30.50 Cr | 362.33 Cr | 80.54 Cr | 281.7860 Cr | 14.99 Cr | -15.51 Cr | 22.62 Cr | 171.67 Cr | 4.90 Cr | 4.52 Cr | -6.00 Cr | 57.2770 Cr |
| 2022-03-31 | 10.80 Cr | 307.20 Cr | 73.21 Cr | 233.9840 Cr | 19.34 Cr | 8.54 Cr | 17.38 Cr | 150.86 Cr | 4.79 Cr | 5.58 Cr | 0.00 Cr | 47.7490 Cr |
| 2021-03-31 | 6.19 Cr | 274.36 Cr | 79.98 Cr | 194.3820 Cr | 30.42 Cr | 24.22 Cr | 14.64 Cr | 147.95 Cr | 4.14 Cr | 3.84 Cr | 0.00 Cr | 53.9110 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 94.8300 Cr | -75.5370 Cr | -16.6810 Cr | 15.7660 Cr | 2.3950 Cr | 15.8360 Cr | -79.4940 Cr | 66.7550 Cr | -10.9260 Cr | -4.4340 Cr | -0.3660 Cr |
| 2024-03-31 | 60.8920 Cr | -76.0480 Cr | -1.9030 Cr | -15.6780 Cr | -17.0590 Cr | 13.4410 Cr | -76.3340 Cr | 41.0090 Cr | 4.0010 Cr | -4.4280 Cr | -2.0680 Cr |
| 2023-03-31 | 87.9370 Cr | -57.2560 Cr | -10.9810 Cr | 38.1320 Cr | 19.7000 Cr | 30.5000 Cr | -47.8190 Cr | 64.9970 Cr | -5.6780 Cr | -4.4220 Cr | -5.2460 Cr |
| 2022-03-31 | 59.0690 Cr | -37.8480 Cr | -16.6140 Cr | 20.3450 Cr | 4.6070 Cr | 10.8000 Cr | -29.7830 Cr | 55.6850 Cr | -11.4150 Cr | -4.4220 Cr | -2.7420 Cr |
| 2021-03-31 | 37.1820 Cr | -31.9240 Cr | -4.5700 Cr | 4.0930 Cr | 0.6880 Cr | 6.1930 Cr | -33.0890 Cr | 28.5400 Cr | -2.8450 Cr | 0.0000 Cr | 2.4950 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 98.63 Cr | 58.69 Cr | 39.95 Cr | 0.4050 | 23.31 Cr | 17.59 Cr | 3.96 | 34.45 Cr | 0.1783 |
| 2025-09-30 | 101.85 Cr | 20.15 Cr | 81.70 Cr | 0.8022 | 23.99 Cr | 19.92 Cr | 4.46 | 36.89 Cr | 0.1956 |
| 2025-06-30 | 97.56 Cr | 56.49 Cr | 41.08 Cr | 0.4210 | 23.83 Cr | 18.89 Cr | 4.25 | 35.44 Cr | 0.1937 |
| 2025-03-31 | 94.44 Cr | 54.65 Cr | 39.79 Cr | 0.4213 | 23.83 Cr | 18.32 Cr | 4.11 | 34.68 Cr | 0.1940 |
| 2024-12-31 | 89.92 Cr | 20.63 Cr | 69.29 Cr | 0.7706 | 23.28 Cr | 21.50 Cr | 4.83 | 34.31 Cr | 0.2390 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 28.14 Cr | 28.32 Cr | 56.46 Cr | 107.22 Cr | 28.60 Cr | 212.82 Cr | 288.59 Cr | 518.16 Cr | 101.77 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 32.32 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -378.85 Cr |
| 2025-03-31 | 15.84 Cr | 16.89 Cr | 32.72 Cr | 106.32 Cr | 25.06 Cr | 187.82 Cr | 261.67 Cr | 466.53 Cr | 87.68 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 27.79 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -342.74 Cr |
| 2024-09-30 | 14.27 Cr | 15.84 Cr | 30.11 Cr | 92.67 Cr | 26.33 Cr | 171.94 Cr | 244.53 Cr | 440.41 Cr | 97.67 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 18.89 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 17.73 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 21.50 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 15.25 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 12.28 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2006-02-24 | February 24, 06 | 5:1 |
Similar Stocks: Medical - Diagnostics & Research
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Dr. Lal PathLabs Limited | LALPATHLAB | ₹1,378.20 | ₹230,122,841,867.00 | ₹247,796.00 |
| Sai Life Sciences Ltd. | SAILIFE | ₹1,010.65 | ₹213,882,616,401.00 | ₹575,569.00 |
| Vijaya Diagnostic Centre Limited | VIJAYA | ₹945.10 | ₹97,085,340,794.00 | ₹75,348.00 |
| Metropolis Healthcare Limited | METROPOLIS | ₹1,818.80 | ₹94,271,859,720.00 | ₹56,277.00 |
Key Executives
Gender: Not Specified
Year Born: 1948
Gender: Not Specified
Year Born:
Gender: male
Year Born: 1951
Gender: male
Year Born: 1976
Gender: male
Year Born:
Gender: female
Year Born: 1974
Gender: female
Year Born: 1976
FAQs about Vimta Labs Limited
The CEO is Sivalinga Prasad Vasireddi.
The current price is ₹439.45.
The range is ₹400.3-902.65.
The market capitalization is ₹1,961.49 crores.
The dividend yield is 0.23%.
The P/E ratio is 26.12.
The company operates in the Healthcare sector.
Overview of Vimta Labs Limited (ISIN: INE579C01029) is a leading Medical - Diagnostics & Research in India. With a market capitalization of ₹1,961.49 crores and an average daily volume of 220,972 shares, it operates in the Medical - Diagnostics & Research. The company last declared a dividend of ₹1.